Rising air pollution is acting as a driver for the increase of the market. Air pollution is a leading environment-related health threat which stands as a risk factor for both acute and chronic respiratory ailments. According to a report from the Forum of International Respiratory Societies (FIRS), tobacco smoke, indoor air pollution from burning fuels, and air pollution from traffic and industrial resources are highlighted as the primary contributing factors for many respiratory ailments. Many diseases and deaths that could result from prolonged exposure to poor indoor air quality occurs primarily in women and children, especially in low-income families. Exposure to indoor smoke used for cooking and warming leads to COPD, lung cancer, and, in children, it causes pneumonia and asthma. This massive population afflicted by respiratory disorders due to air pollution is driving the market for cough syrup market since it's a crucial medicine used for treating these ailments.
The global cough syrup market has been segmented into product type, category, and application. Based on product type, the marketplace was segregated into conjunction and people. Combination product type was further classified as dextromethorphan + guaifenesin, guaifenesin + pseudoephedrine, and brompheniramine + pseudoephedrine. The individual product type has been further split into dextromethorphan, guaifenesin, ambroxol, and codeine. Based on the class, the market was segmented into cough suppressants and expectorants. And by application, the cough syrup marketplace has been categorized as adults and children.
The worldwide cough syrup market, based on area, has been divided to the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to maintain a maximum share of this global cough syrup market, and also the regional economy is projected to register a CAGR of 3.16percent throughout the forecast period. The existence of significant market players in the region, strategic acquisitions by major players to enhance product portfolio, raising cases of respiratory disorders, and access to advanced medications for the treatment of chronic obstructive pulmonary disease (COPD) is expected to push the market growth within this region to combat these issues effectively through using cough syrups.